Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Dow
McKinsey
Merck
Baxter

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

DUOPA Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Duopa, and what generic alternatives are available?

Duopa is a drug marketed by Abbvie Inc and is included in one NDA.

The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

Drug patent expirations by year for DUOPA
Drug Prices for DUOPA

See drug prices for DUOPA

Pharmacology for DUOPA
Synonyms for DUOPA
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
500019-90-9
57308-51-7
AC1L2XHE
Carbidopa / Levodopa
CARBIDOPA AND LEVODOPA
Carbidopa Levodopa
Carbidopa mixture with Levodopa
Carbidopa-L-dopa mixt
Carbidopa-L-dopa mixt.
Carbidopa-levodopa (1:10)
Carbidopa-levodopa ER
Carbidopa-levodopa extended release
Carbidopa-levodopa mixt
Carbidopa-levodopa mixt.
carbidopa, levodopa drug combination
CHF 1512
Co-careldopa
CR-3
CR-5
DM-1992
Dopabain
Duodopa
IPX 066
IPX066
Isicom
IVTMXOXVAHXCHI-YXLMWLKOSA-N
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1)
Levodopa / carbidopa
levodopa carbidopa
Levodopa-carbidopa (10:1)
Levodopa/Carbidopa Solution
LS-158296
Nacom
Nakom
ND 0612
ND0612
Rytary
SCHEMBL2049245
Sinemet CR
Sinemet CR4

US Patents and Regulatory Information for DUOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie Inc DUOPA carbidopa; levodopa SUSPENSION;ENTERAL 203952-001 Jan 9, 2015 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Medtronic
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.